Aurora Spine Announces Presentation on DEXA Technology at the American Association of Neurological Surgeons Annual Meeting
April 12 2023 - 7:00AM
Aurora Spine Corporation (“Aurora Spine” or the
“Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer
of innovative medical devices that improve spinal surgery outcomes,
today announced that its DEXA Technology will be highlighted at a
presentation delivered by Dr. Sebastian Koga, neurosurgeon at
Forrest Health Institute of Neuroscience, at the 2023 American
Association of Neurological Surgeons (AANS) Annual Scientific
Meeting. The meeting will be held on April 21-24, 2023, at the Los
Angeles Convention Center. Dr. Koga’s presentation titled
‘Comparative Subsidence Analysis Between 3D Printed Bone Density
Matched Titanium and PEEK Cervical Interbody Fusion Devices’ will
be delivered on Sunday, April 23rd at 2pm.
Dr. Koga’s presentation will discuss subsidence,
which occurs when the vertebral disc experiences cavitating or
sinking around an implant. Subsidence can be a potential
complication of cervical and lumbar interbody fusion devices, and
may lead to the loss of stabilization, lordosis, and vertebral
height. This is typically due to a stiffness mismatch between the
implant material and the cervical body/endplate. The discussion
will also compare subsidence characteristics between a
stiffness-matched 3d printed porous titanium cage (Aurora Spine’s
DEXA-C™) and a PEEK cage of identical footprint and show the
results of this research, which revealed that the DEXA-C device has
a 43% lower propensity to subside than the generic PEEK cages and
was 17% more resistant to collapse due to compression. The results
also indicated that the PEEK cage subsides a 10% greater distance
into the superior endplate than the DEXA-C cage.
Dr. Sebastian Koga said, “There has been little
progress in spinal biomaterials until now, because we were pursuing
stronger and stiffer constructs. Our current approach is based on
biomimetic principles, and a lot of basic science work has gone
into matching the elastic modulus of natural human vertebral bone.
Thus, we have designed a range of implants which are appropriate
for patients with low bone density scores.”“This evolution in
spinal interbody cages allows us to operate on an increasingly
older population with implants tailored to their bone quality.
Future iteration will match the morphology of the disc spaces to
reduce voids and increase endplate contact, but we have already
proven that elastic properties play a large role in reducing
endplate fractures and increasing fusion,” added Dr. Koga.
Mr. Trent Northcutt, Aurora’s President, CEO,
and co-founder, stated, "We are very excited with Dr. Koga’s
presentation at this year’s AANS meeting, which will demonstrate
the strength of the DEXA-C device and its superior performance to
standard PEEK and 3D printed cages currently being implanted. We
believe that the DEXA-C’s proprietary design and technology, to
match with a patient’s bone density, showed to be a superior
implant in preventing subsidence and other complications patients
can suffer from when using cages that don’t consider a patient’s
bone density.”
About Aurora Spine
Aurora Spine is focused on bringing new
solutions to the spinal implant market through a series of
innovative, minimally invasive, regenerative spinal implant
technologies. Additional information can be accessed at
www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking
information that involves substantial known and unknown risks and
uncertainties, most of which are beyond the control of Aurora
Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking
Information" in Aurora Spine's final prospectus (collectively,
"forward-looking information"). Forward-looking information in this
news release includes information concerning the proposed use and
success of the company’s products in surgical procedures. Aurora
Spine cautions investors of Aurora Spine's securities about
important factors that could cause Aurora Spine's actual results to
differ materially from those projected in any forward-looking
statements included in this news release. Any statements that
express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance are
not historical facts and may be forward-looking and may involve
estimates, assumptions and uncertainties which could cause actual
results or outcomes to differ unilaterally from those expressed in
such forward-looking statements. No assurance can be given that the
expectations set out herein will prove to be correct and,
accordingly, prospective investors should not place undue reliance
on these forward-looking statements. These statements speak only as
of the date of this press release and Aurora Spine does not assume
any obligation to update or revise them to reflect new events or
circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
Adam Lowensteiner
LYTHAM PARTNERS, LLC
Phoenix | New York
Telephone: 646-829-9700
asapf@lythampartners.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Oct 2023 to Oct 2024